Washington DC's Top Rated Online Weed Delivery Service

Find Weed, CBD, Psychedelics in Washington DC

You are currently viewing Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas

Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas

Earlier this year, we provided a micro-scholarship for Laurel Kilgour’s 5-week Stanford summer course, Far from Far Out: Policy Perspectives on the Psychedelic Renaissance. Erin Eberle received the scholarship and completed the course. Here, Erin shares some key takeaways…This summer attorney Laurel Kilgour offered a five week survey course on the state of psychedelic policy for Stanford Continuing Studies. This…

December 5, 2022

Psychedelics

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations

In this week’s episode, Joe and Alexa talk about the excitement brewing around our first conference-meets-festival, Convergence (March 30 – April 2 at the Wisdome in LA), and some of the sponsorships starting to come in (interested? email Alexa@psychedelicstoday.com). Then, they dive into what intrigued them the most this week: a study looking into potentiality and possible causes of 5-MeO-DMT reactivation…

December 4, 2022

Psychedelics

A Deeper Look at Psychedelics Anonymous

Building a psychedelic community isn’t easy. Psychedelics are emerging into a landscape dotted with brands that understand the power of community and are trying to weave it into a business model. Yet, creating a community around a brand or product doesn’t happen overnight and needs special conditions to grow. Communities are emergent and don’t always pop up where we expect.…

December 3, 2022

Psychedelics

“How to Change Your Mind” Netflix Docuseries: Does it Change Yours?

Episode 3: MDMA Short take: an episode for the evidence-based mind Long take: I believe this episode won the day for people who wanted less history and mystery and more data-driven narratives. The tone shift is a byproduct of the fact that MDMA doesn’t date back to indigenous Amazon tribes, Native Americans, or even Timothy Leary. In 1912, pharmaceutical company…

December 2, 2022